Results 181 to 190 of about 1,608 (196)

L86

2021
openaire   +1 more source

An elderly advanced non-small cell lung cancer patient harboring rare epidermal growth factor receptor mutations L861R benefited from afatinib

Medicine (United States), 2021
Xin Yan
exaly  

Afatinib response in a lung adenocarcinoma with novel compound S720F+L861R mutation in EGFR

Lung Cancer, 2020
Wenjuan Jiang, Nong Yang, Yongchang Zhang   +2 more
exaly  

Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells

Biochemical Pharmacology, 1993
Maryalice Stetler-Stevenson, Oliver Sartor, Edward A Sausville   +2 more
exaly  

Beyond Transference: When the Therapist's Real Life Intrudes—edited by Judith H. Gold, M.D., F.R.C.P.C., and John C. Nemiah, M.D.; Washington, D.C., American Psychiatric Press, 1993, l86 pages, $27.50

Psychiatric Services, 1994
openaire   +1 more source

Molecular masquerading of rare EGFR L858M/L861R mutations as common L858R/L861Q mutations by PNA clamping assay

Pathology, 2017
Ji Hyung Hong, Seung-Hyun Jung, Sug Hyung Lee   +2 more
exaly  

Erlotinib Response in an NSCLC Patient with a Novel Compound G719D+L861R Mutation in EGFR

Journal of Thoracic Oncology, 2013
Dara L Aisner, Robert C Doebele
exaly  

Osimertinib in uncommon EGFR exon 21 L861R and EGFR exon 18 deletion-insertion mutant non-small cell lung cancer—case report

Translational Lung Cancer Research
Yang Wang, Surein Arulananda
exaly  

Growth Inhibition With Reversible Cell Cycle Arrest of Carcinoma Cells by Flavone L86-8275

Journal of the National Cancer Institute, 1992
exaly  

Lung adenocarcinoma with EGFR L858R-K860I and L858R-L861F doublet mutations from which the L858R mutation is undetectable through the cobas EGFR mutation test v2

Pathology Research and Practice
Man-San Zhang, Yen-Lin Huang, Min-Shu Hsieh   +2 more
exaly